NMT gets back on track with STARFlex heart implant
This article was originally published in Clinica
Executive Summary
Following a setback with the US FDA last year, Boston, Massachusetts implant specialist NMT Medical is renewing efforts to gain market approval for its STARFlex implant for closing a heart defect that can increase the risk of stroke.